Vesencumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | neuropilin 1 |
| Clinical data | |
| ATC code | none |
| Identifiers | |
| CAS Number |
1205533-60-3  |
| ChemSpider | none |
| Chemical and physical data | |
| Formula | C6430H9948N1708O2016S48 |
| Molar mass | 145.0 kg/mol |
 (what is this?) (verify) | |
Vesencumab is an immunomodulator designed for the treatment of solid malignancies.[1] It binds to neuropilin 1.[2]
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Vesencumab, American Medical Association.
- ↑ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information. 24 (4).
This article is issued from Wikipedia - version of the 10/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.